About Ipsen:

Ipsen is a mid-sized global biopharmaceutical company with a focus on transformative medicines in three therapeutic areas: Oncology Rare Disease and Neuroscience. Supported by nearly 100 years of development experience with global hubs in the U.S. France and the U.K we tackle areas of high unmet medical need through research and innovation.

Our passionate teams in more than 40 countries are focused on what matters and endeavor every day to bring medicines to patients in 88 countries. We build a workplace that champions human-centric leadership and fosters a culture of collaboration excellence and impact. At Ipsen every individual is empowered to be their true selves grow and thrive alongside the companys success. Join us on our journey towards sustainable growth creating real impact on patients and society!

For more information visit us at follow our latest news on LinkedIn and Instagram.

SUMMARY AND PURPOSE OF THE POSITION

The Global Value & Access Director for Business Development & New Products Planning is responsible for leading:

• High quality strategic value access and pricing insights into all business development assessments

• Develops early evidence plans access and pricing scenarios for new products within our pipeline across our three therapeutic areas neuroscience oncology and rare disease.

• Undertakes payer research with key health authorities and HTA agencies to ensure payer value drivers are clearly understood and embedded in evidence programs at early stages of product development.

• Drives execution of Value & Access projects within cross-functional team setting

• Closely monitor external environment and global access development across priority therapeutic areas to inform access and evidence generation strategies.

• Is an effective enterprise leader working across R&D medical access commercial and other core global functions.

MAIN RESPONSIBILITIES & TECHNICAL COMPETENCIES

Lead Business Development Across Value & Access:

1. Core member of Search and Triage meetings across franchises. Close partnership with Commercial NPP BD External Innovation Global Clinical and Medical teams as well as US New Products teams to ensure efficiency and speed in triage as well as holistic input on incoming assets from assessment to DD.

2. Thorough and consistent pricing reimbursement and access assessment for potential assets (early and late stage) in alignment with franchise portfolio priorities. This includes:

• Working with team to understand relevant epidemiology current treatment patterns (SOC) and competitive landscape

• Understanding payers perceptions of the disease and relevant endpoints and value proposition based on magnitude of benefit offered by potential asset

• Conducting HTA and analogue analysis to support internal assumptions

• Pricing potential (scenarios) GTN and access strategies

3. Maximize internal knowledge and efficiencies with external partners.

4. Standardization of Value & Access Pricing and Access input in key TAs of interest aligned with identified Franchise priorities in partnership with Franchise VPs to ensure consistency of Value & Access BD input maximize efficiencies/economies of scale and optimize internal knowledge and capabilities (internal GMAP BD Database).

5. Deep understanding of external reimbursement landscape and policy developments in key markets assessment of their potential pricing and access impact on BD assets and standardization of assumptions across assets and TAs (e.g. DE AMNOG updates US IRA etc).

6. Close monitoring of external BD developments (in collaboration with BD and CI teams) across TAs of interest to best inform internal pricing and access decision making and ensure competitive positioning for IPSEN.

7. Representation of Value & Access (in partnership with TA VPs) in key Leadership fora on BD assessments and DD.

KNOWLEDGE AND EXPERIENCE

Knowledge & Experience (essential):

• At least 10 years of above country Market Access & Pricing experience

• Experience working on local HTA submissions and pricing strategies

• Ability to connect clinical development payer needs and commercial opportunities

• Proven experience in successfully managing multiple international projects deadlines in a hands-on manner within a fast-paced work environment in full compliance with laws regulations and policies

• Ability to work independently and confidently but also in close collaboration with a broad range of stakeholders

• Technical knowledge of economic evaluations in Healthcare

• Knowledge of international health care systems and ongoing reforms

• Ability to develop Market Access strategy and Pricing strategy

• Solid business background enabling the assessment competitive impact on payer strategies and the ability to challenge strategy and tactics

• Ability to work under pressure to take accountability for business challenges think strategically and tackle complex problems

• Executive presence and ability to interact effectively with all levels of the organization

• Proven ability to build coalitions and develop strong partnerships across functions

• Strong analytical skill

Education / Certifications (essential):

• Ideal: both scientific background and business focus

Language(s) (essential):

• Fluent English is compulsory

#LI-Hybrid